MENU
+Compare
VERA
Stock ticker: NASDAQ
AS OF
Apr 24, 04:59 PM (EDT)
Price
$23.46
Change
+$1.12 (+5.01%)
Capitalization
1.36B

VERA Vera Therapeutics Forecast, Technical & Fundamental Analysis

Vera Therapeutics Inc is a clinical stage biotechnology company... Show more

VERA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for VERA with price predictions
Apr 23, 2025

VERA in +5.78% Uptrend, rising for three consecutive days on April 23, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where VERA advanced for three days, in of 247 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where VERA's RSI Oscillator exited the oversold zone, of 20 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 42 cases where VERA's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on April 22, 2025. You may want to consider a long position or call options on VERA as a result. In of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for VERA just turned positive on April 14, 2025. Looking at past instances where VERA's MACD turned positive, the stock continued to rise in of 39 cases over the following month. The odds of a continued upward trend are .

VERA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VERA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for VERA entered a downward trend on April 21, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.364) is normal, around the industry mean (14.056). P/E Ratio (0.000) is within average values for comparable stocks, (63.446). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.788). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (252.992).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. VERA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VERA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
VERA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

VERA is expected to report earnings to rise 2.00% to -73 cents per share on May 08

Vera Therapeutics VERA Stock Earnings Reports
Q1'25
Est.
$-0.73
Q4'24
Beat
by $0.09
Q3'24
Missed
by $0.21
Q2'24
Missed
by $0.06
Q1'24
Missed
by $0.03
The last earnings report on February 26 showed earnings per share of -72 cents, beating the estimate of -81 cents. With 285.72K shares outstanding, the current market capitalization sits at 1.36B.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
8000 Marina Boulevard
Phone
+1 650 770-0077
Employees
51
Web
https://www.veratx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VMIDX21.38N/A
N/A
VALIC Company I Mid Cap Index
HRLRX8.83N/A
N/A
Hartford Real Asset R3
ITGRX35.96N/A
N/A
Macquarie Global Growth Fund R6
JHQRX30.42N/A
N/A
JPMorgan Hedged Equity R6
MVGIX17.19N/A
N/A
MFS Low Volatility Global Equity I

VERA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, VERA has been loosely correlated with DNLI. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if VERA jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VERA
1D Price
Change %
VERA100%
+4.39%
DNLI - VERA
45%
Loosely correlated
+1.85%
CRNX - VERA
44%
Loosely correlated
+3.55%
XNCR - VERA
43%
Loosely correlated
+2.07%
ROIV - VERA
42%
Loosely correlated
+2.98%
XENE - VERA
42%
Loosely correlated
+2.23%
More